Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023)
Beteiligte:
Homan, Matjaž;
Jones, Nicola L.;
Bontems, Patrick;
Carroll, Matthew W.;
Czinn, Steven J.;
Gold, Benjamin D.;
Goodman, Karen;
Harris, Paul R.;
Jerris, Robert;
Kalach, Nicolas;
Kori, Michal;
Megraud, Francis;
Rowland, Marion;
Tavares, Marta
Erschienen:
Wiley, 2024
Erschienen in:
Journal of Pediatric Gastroenterology and Nutrition, 79 (2024) 3, Seite 758-785
Sprache:
Englisch
DOI:
10.1002/jpn3.12314
ISSN:
1536-4801;
0277-2116
Entstehung:
Anmerkungen:
Beschreibung:
AbstractBackgroundEvolving epidemiological data and increasing antibiotic resistance mandate an update of the European and North American Societies of Pediatric Gastroenterology, Hepatology and Nutrition guidelines.MethodsCertainty of evidence and strength of recommendations were rated by experts according to the Grading of Recommendation Assessment, Development, and Evaluation approach. PICO (patient population, intervention, comparator, and outcome) questions were developed and voted on by the group. Recommendations were formulated using the Evidence to Decision framework.ResultsThe current literature supports many of the previous recommendations and several new recommendations. Invasive testing with strain antimicrobial susceptibility analysis is recommended for the diagnosis and selection of eradication therapy for H. pylori infection. Molecular methods are acceptable for detection of infection and of antibiotic resistance in gastric biopsy specimens. Reliable, noninvasive tests can be used as a screening method for children with history of gastric cancer in a first‐degree relative. When investigating causes of chronic immune thrombocytopenic purpura, testing for H. pylori is no longer recommended. When investigating other diseases such as inflammatory bowel disease, celiac disease, or eosinophilic esophagitis, specific diagnostic biopsies for H. pylori infection are not indicated. However, if H. pylori is an incidental finding, treatment may be considered after discussing the risks and benefits. Treatment should be based on antibiotic antimicrobial susceptibility testing and, if unavailable, regimens containing clarithromycin should be avoided.ConclusionsDue to decreasing prevalence of infection, increasing challenges with antibiotic resistance, and emerging evidence regarding complications of infection, clinicians must be aware of these recommended changes to appropriately manage H. pylori infection and its clinical sequelae in children.